Princeton Alpha Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-6,656
Closed -$477K 622
2016
Q4
$477K Sell
6,656
-9,277
-58% -$690K 0.1% 319
2016
Q3
$1.26M Buy
15,933
+6,384
+67% +$519K 0.24% 118
2016
Q2
$797K Sell
9,549
-32,689
-77% -$2.9M 0.14% 224
2016
Q1
$3.88M Buy
42,238
+2,284
+6% +$206K 0.63% 17
2015
Q4
$4.04M Buy
39,954
+29,939
+299% +$3.12M 0.69% 12
2015
Q3
$983K Sell
10,015
-7,725
-44% -$858K 0.2% 138
2015
Q2
$2.08M Buy
+17,740
New +$1.94M 0.41% 49
2015
Q1
Sell
-15,904
Closed -$1.5M 766
2014
Q4
$1.5M Sell
15,904
-24,230
-60% -$2.51M 0.42% 40
2014
Q3
$4.27M Buy
+40,134
New +$3.93M 0.97% 4
2014
Q1
Sell
-5,968
Closed -$448K 660
2013
Q4
$448K Buy
+5,968
New +$416K 0.33% 75

Other funds holding GILD

Princeton Alpha Management's GILD Position: Q1 2017 in Review

Princeton Alpha Management sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 6,656 shares — an estimated $477K sold.

Princeton Alpha Management first reported a position in GILD in Q4 2013 and held it in 10 quarters. The position peaked at $4.27M in Q3 2014. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Princeton Alpha Management reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • Princeton Alpha Management sold 6,656 Gilead Sciences shares in Q1 2017, an estimated $477K.
  • Princeton Alpha Management first reported a position in Gilead Sciences in Q4 2013 and held it in 10 quarters.
  • Princeton Alpha Management's Gilead Sciences position peaked at $4.27M in Q3 2014.
  • 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Princeton Alpha Management's 13F filing for Q1 2017, filed 3 May 2017.